Patents by Inventor Benjamin Pless

Benjamin Pless has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070293854
    Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.
    Type: Application
    Filed: August 9, 2007
    Publication date: December 20, 2007
    Inventors: Benjamin PLESS, Scott Anderson, Jonathan Podmore, Matthias Vaska, John Crowe, Roxanne Richman, Timothy Ciciarelli, David Gallup, Jack Ulstad
  • Publication number: 20070213783
    Abstract: An implantable neurostimulator system for treating pain includes scheduled and responsive therapy capabilities including responsive stimulation applied to the brain and peripheral sections of the nervous system. Methods for treating chronic nociceptive, neuropathic, and psychogenic pain employ an inventive system to advantageously reduce multiple symptoms and components of pain and to address underlying causes of pain.
    Type: Application
    Filed: March 13, 2006
    Publication date: September 13, 2007
    Applicant: NeuroPace, Inc.
    Inventor: Benjamin Pless
  • Publication number: 20070213784
    Abstract: A system and method for detecting neurological conditions, including periods of high ictal activity and periods of low ictal activity, uses a relatively low-power central processing unit in connection with signal processing circuitry to identify characteristics of an electrographic signal received from a patient's brain. Cerebral blood flow may also be monitored. Observed characteristics are used to drive targeted responsive therapy and suppressive responsive therapy, or the modulation of cerebral blood flow, to prevent or terminate imminent seizures and to reduce the likelihood of future seizures.
    Type: Application
    Filed: March 13, 2006
    Publication date: September 13, 2007
    Applicant: NeuroPace, Inc.
    Inventor: Benjamin Pless
  • Publication number: 20070142886
    Abstract: Disclosed is a means and method for the treatment of migraine headaches and other disorders of the human body by the application of one or more intense magnetic pulses. By placing an intense magnetic field pulse(s) onto a certain region of the brain, an electrical current can be generated in the cerebral cortex that can stop a migraine headache in some patients or at least decrease its severity. The device to perform this function can be called a “magnetic pulser system.” This system can be made in one piece and powered by plugging into a household or automobile receptacle or from a battery. The pulser system uses capacitors that are first charged to a high voltage and then discharged into a coil that creates the intense magnetic pulse. Both visual and auditory signals can be provided by the pulser system to assist the patient in using the device.
    Type: Application
    Filed: December 19, 2005
    Publication date: June 21, 2007
    Inventors: Robert Fischell, Scott Fischell, David Fischell, Emily Ma, Kuen Chang, Dave Vondle, Benjamin Pless
  • Publication number: 20070038265
    Abstract: An implantable neurostimulator system for treating movement disorders includes a sensor, a detection subsystem capable of identifying episodes of a movement disorder by analyzing a signal received from the sensor, and a therapy subsystem capable of applying therapeutic electrical stimulation to treat the movement disorder. The system treats movement disorders by detecting physiological conditions characteristic of an episode of symptoms of the movement disorder and selectively initiating therapy when such conditions are detected.
    Type: Application
    Filed: September 8, 2006
    Publication date: February 15, 2007
    Applicant: NeuroPace, Inc.
    Inventors: Thomas Tcheng, Robert Fischell, Benjamin Pless
  • Publication number: 20070016094
    Abstract: A system and method for detecting and predicting neurological events with an implantable device uses a relatively low-power central processing unit in connection with signal processing circuitry to identify features (including half waves) and calculate window-based characteristics (including line lengths and areas under the curve of the waveform) in an electrographic signal received from a patient's brain. The features and window-based characteristics are combinable in various ways according to the invention to detect and predict neurological events in real time, enabling responsive action by the implantable device.
    Type: Application
    Filed: October 25, 2004
    Publication date: January 18, 2007
    Applicant: NeuroPace, Inc.
    Inventor: Benjamin Pless
  • Publication number: 20060265022
    Abstract: A system including an implantable neurostimulator device capable of modulating cerebral blood flow to treat epilepsy and other neurological disorders. In one embodiment, the system is capable of modulating cerebral blood flow (also referred to as cerebral perfusion) in response to measurements and other observed conditions. Perfusion may be increased or decreased by systems and methods according to the invention as clinically required.
    Type: Application
    Filed: April 14, 2006
    Publication date: November 23, 2006
    Applicant: NeuroPace, Inc.
    Inventors: Michael John, Benjamin Pless
  • Publication number: 20060224216
    Abstract: A system and method for controlling epilepsy and other neurological disorders by providing electrical stimulation to a patient's brain in response to detected neurological conditions. An implantable device includes a stimulation subsystem coupled to a stimulation electrode to provide responsive electrical brain stimulation in response to an event detected via an on-board processor's analysis of data received from a detection subsystem coupled to a detection electrode located in a different portion of the patient's brain.
    Type: Application
    Filed: May 16, 2006
    Publication date: October 5, 2006
    Inventors: Benjamin Pless, Robert Fischell, David Fischell
  • Publication number: 20060212092
    Abstract: An interactive implantable medical device system includes an implantable medical device and a network-enabled external device capable of bi-directional communication and interaction with the implantable medical device. The external device is programmed to interact with other similarly-enabled devices. The system facilitates improved patient care by eliminating unnecessary geographic limitations on implantable medical device interrogation and programming, and by allowing patients, physicians, and other users to access medical records, history, and information and to receive status and care-related alerts and messages anywhere there is access to a communications network.
    Type: Application
    Filed: May 16, 2006
    Publication date: September 21, 2006
    Inventors: Benjamin Pless, David Fischell, Barbara Gibb, Lisa Guzzo, Adrian Upton
  • Publication number: 20060212093
    Abstract: An implantable neurostimulator system adapted to provide therapy for various neurological disorders is capable of varying therapy delivery strategies based on the context, physiological or otherwise, into which the therapy is to be delivered. Responsive and scheduled therapies can be varied depending on various sensor measurements, calculations, inferences, and device states (including elapsed times and times of day) to deliver an appropriate course of therapy under the circumstances.
    Type: Application
    Filed: May 16, 2006
    Publication date: September 21, 2006
    Inventors: Benjamin Pless, Thomas Tcheng
  • Publication number: 20060129204
    Abstract: A system including an implantable neurostimulator device capable of modulating cerebral blood flow to treat epilepsy and other neurological disorders. In one embodiment, the system is capable of modulating cerebral blood flow (also referred to as cerebral perfusion) in response to measurements and other observed conditions. Perfusion may be increased or decreased by systems and methods according to the invention as clinically required.
    Type: Application
    Filed: December 15, 2004
    Publication date: June 15, 2006
    Applicant: NeuroPace, Inc.
    Inventors: Benjamin Pless, Brett Wingeier
  • Publication number: 20050251125
    Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.
    Type: Application
    Filed: June 28, 2004
    Publication date: November 10, 2005
    Applicant: EPICOR MEDICAL, INC.
    Inventors: Benjamin Pless, Scott Anderson, Jonathan Podmore, Matthias Vaska, John Crowe, Roxanne Richman, Timothy Ciciarelli, David Gallup, Jack Ulstad
  • Publication number: 20050222641
    Abstract: This is a neurostimulator that is configured to treat epilepsy and other neurological disorders using certain stimulation strategies, particularly changing various pulse parameters, during the imposition of a burst of those pulses. The invention includes the processes embodying those stimulation strategies.
    Type: Application
    Filed: May 31, 2005
    Publication date: October 6, 2005
    Inventor: Benjamin Pless
  • Patent number: 6949095
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: September 27, 2005
    Assignee: Epicor Medical, Inc.
    Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
  • Publication number: 20050033274
    Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.
    Type: Application
    Filed: June 28, 2004
    Publication date: February 10, 2005
    Applicant: EPICOR MEDICAL, INC., A Delaware Corporation
    Inventors: Benjamin Pless, Scott Anderson, Jonathan Podmore, Matthias Vaska, John Crowe, Roxanne Richman, Timothy Ciciarelli, David Gallup, Jack Ulstad
  • Publication number: 20040260278
    Abstract: The invention provides apparatus and methods for ablating tissue and is particularly useful for creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus has a suction well which is adhered to the tissue to be ablated. The ablating element is surrounded by the suction well. A fluid is delivered to the ablating element to conduct RF energy to the tissue and/or to cool the tissue. The device is preferably formed with a number of cells with each cell having a suction well and at least one ablating element. The device also preferably has a locking mechanism for locking one part of the device to another part of the device to form a closed loop for ablating around structures such as the pulmonary veins.
    Type: Application
    Filed: April 12, 2004
    Publication date: December 23, 2004
    Inventors: Scott C. Anderson, Jonathan L. Podmore, Roxanne L. Richman, Matthias Vaska, David A. Gallup, John E. Crowe, Jack E. Ulstad, Benjamin Pless
  • Patent number: 6805128
    Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.
    Type: Grant
    Filed: July 12, 2000
    Date of Patent: October 19, 2004
    Assignee: Epicor Medical, Inc.
    Inventors: Benjamin Pless, Scott C. Anderson, Jonathan L. Podmore, Matthias Vaska, John E. Crowe, Roxanne L. Richman, Timothy Ciciarelli, David A. Gallup, Jack E. Ulstad, Jr.
  • Patent number: 6805129
    Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: October 19, 2004
    Assignee: Epicor Medical, inc.
    Inventors: Benjamin Pless, Scott C. Anderson, Jonathan L. Podmore, Matthias Vaska, John E. Crowe, Roxanne L. Richman, Timothy Ciciarelli, David A. Gallup, Jack E. Ulstad, Jr.
  • Patent number: 6645202
    Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: November 11, 2003
    Assignee: Epicor Medical, Inc.
    Inventors: Benjamin Pless, Scott C. Anderson, Jonathan L. Podmore, Matthias Vaska, John E. Crowe, Roxanne L. Richman, Timothy Ciciarelli, David A. Gallup, Jack E. Ulstad, Jr.
  • Publication number: 20030079753
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Application
    Filed: August 30, 2002
    Publication date: May 1, 2003
    Applicant: EPICOR, INC.
    Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Scott C. Anderson, Roxanne L. Richman